Cosmos Health Inc. (COSM)
NASDAQ: COSM · Real-Time Price · USD
0.703
-0.017 (-2.29%)
At close: Nov 4, 2024, 4:00 PM
0.705
+0.002 (0.26%)
After-hours: Nov 4, 2024, 4:47 PM EST
Cosmos Health Revenue
Cosmos Health had revenue of $13.21M in the quarter ending June 30, 2024, with 6.82% growth. This brings the company's revenue in the last twelve months to $56.45M, up 15.73% year-over-year. In the year 2023, Cosmos Health had annual revenue of $53.38M with 6.02% growth.
Revenue (ttm)
$56.45M
Revenue Growth
+15.73%
P/S Ratio
0.19
Revenue / Employee
$458,983
Employees
123
Market Cap
12.48M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 53.38M | 3.03M | 6.02% |
Dec 31, 2022 | 50.35M | -5.89M | -10.48% |
Dec 31, 2021 | 56.24M | 833.33K | 1.50% |
Dec 31, 2020 | 55.41M | 15.73M | 39.65% |
Dec 31, 2019 | 39.68M | 2.59M | 6.99% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionCOSM News
- 3 days ago - Cosmos Health's Subsidiary CosmoFarm Achieves Record Revenue, Up 8.62% to $43 Million YTD 2024, with Gross Profit Rising 21% - Accesswire
- 5 weeks ago - Cosmos Health Reports Strong 160% Increase in 2024 YTD Sales on Amazon UK for Its Proprietary Brands - Accesswire
- 6 weeks ago - Cosmos Health Receives Initial Orders Exceeding $500,000 for C-Scrub in the UK; Future Orders Booked at Accelerated Pace with Strong Profitability Anticipated Due to High Profit Margins - Accesswire
- 6 weeks ago - Cosmos Health Expands Global Presence into India, a Market with Over 1.4Bn People, Through Exclusive Agreement to Distribute Virax Biolabs' Mpox PCR Detection Kits - Accesswire
- 6 weeks ago - Cosmos Health Enters Development Phase for CCDL24, an Innovative Multitargeting Product for Gastrointestinal Disorders, with a Market Size Valued at Over $37.5 Billion - Accesswire
- 6 weeks ago - Cosmos Health Releases 2024-2027 Updated Guidance; Projects Revenue of $155.8M and Adjusted EBITDA of $29.4M Annually by 2027, Driven by Strategic Focus on High-Margin Segments - Accesswire
- 7 weeks ago - Cosmos Health Secures Exclusivity Agreement with Virax Biolabs to Distribute mpox PCR Kits across the GCC, including the UAE, Saudi Arabia, Bahrain, Kuwait, Oman, and Qatar - Accesswire
- 7 weeks ago - Virax Biolabs Announces Extension of Existing Exclusive Distribution Agreement to Market Mpox (formerly Monkeypox) Virus Real-Time PCR Detection Kits with Cosmos Health Inc. - PRNewsWire